Clinical trial / 2017
Potato protease inhibitor II suppressed postprandial appetite and elevated cholecystokinin in women.
In a randomized crossover trial, 44 healthy women ingested placebo or potato extract standardized to 15 mg or 30 mg potato protease inhibitor II one hour before a 390 kcal breakfast. Both doses significantly lowered postprandial hunger, prospective consumption, and desire to eat while increasing fullness. The 15 mg dose significantly increased plasma cholecystokinin levels over three hours, with no significant differences observed in glucose or insulin.
- Study type
- Randomized double-blind crossover trial
- Who was studied
- 44 healthy women
- What was measured
- Postprandial appetite sensations, cholecystokinin, glucose, and insulin
THE PAPER
Potato protease inhibitor II suppresses postprandial appetite in healthy women: a randomized double-blind placebo-controlled trial.
Zhu Y, Lasrado JA, Hu J. Food Funct, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.